Research progress on programmed death receptor 1/ ligand 1 inhibitor in immunotherapy of head and neck squamous cell carcinoma

Research progress on programmed death receptor 1/ ligand 1 inhibitor in immunotherapy of head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is a common malignant tumor that seriously threatens human health and life. With increasing studies on the mechanism of tumor immune escape, programmed death receptor 1 (PD-1) and programmed death ligand receptor 1 (PD-L1) have been proven to be involved...

Full description

Bibliographic Details
Main Authors: ZENG Fei, LU Jie, SUN Renhao, FANG Yikang, YU Wenyi, YANG Fang, ZHAO Lu
Format: Article
Language:zho
Published: Editorial Department of Journal of Prevention and Treatment for Stomatological Diseases 2021-10-01
Series:口腔疾病防治
Subjects:
head and neck squamous cell carcinoma，
programmed death receptor 1，
programmed death receptor ligand 1，
immunotherapy，
programmed death receptor 1 inhibitor，
programmed death receptor ligand 1 inhibitor，
nivolumab，
pembrolizumab，
durvalumab，
atezolizumab，
Online Access:http://www.kqjbfz.com/CN/10.12016/j.issn.2096-1456.2021.10.010

Internet

http://www.kqjbfz.com/CN/10.12016/j.issn.2096-1456.2021.10.010

Similar Items